Status:
COMPLETED
Control of Pregnancy Associated Malaria With Intermittent Preventive Treatment
Lead Sponsor:
DBL -Institute for Health Research and Development
Conditions:
Anaemia
Malaria
Eligibility:
FEMALE
14-45 years
Phase:
NA
Brief Summary
Malaria is one of the major causes of illness and mortality in Sub-Saharan Africa. In Ghana, malaria is the most important cause of morbidity and accounts for about 40% of outpatient contacts. Chemopr...
Detailed Description
General Objective To evaluate an alternative strategy of community involvement in the control of pregnancy associated malaria and anaemia in an area of intense malaria transmission in Ghana. Specific...
Eligibility Criteria
Inclusion
- Primigravida
- Secundigravida
- Permanent resident
- Hemoglobin (Hb) \> 7 g/dl
Exclusion
- Hb \< 7 g/dl
- Allergy to sulpha
- Multiple pregnancy
- Chronic diseases
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT00258024
Start Date
November 1 2005
End Date
October 1 2007
Last Update
February 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Afiya Sekyere district
Kumasi, Ashanti Region, Ghana